Patient Engagement Systems is a patient engagement & decision-support healthcare information technology company focused on the diabetes & chronic kidney disease markets.  The company provides a patent-pending chronic disease treatment decision support platform delivering its solution to customers via software-as-a-service.

University of Vermont professors Ben Littenberg, MD and Charles MacLean, MD, partnered with Michael Gagnon, a senior technology infrastructure and information security executive, to found Vermedx® in 2006.  CEO Stan Goldstein joined the team in 2011.

Patient Engagement Systems provides critical information automatically and as needed to enable doctors, patients, and provider organizations to significantly improve the health of large populations of diabetic & CKD patients, thereby dramatically driving down treatment related costs.  Existing customers have chosen Vermedx® based on its unique, clinically proven ability to deliver annualized net per patient savings exceeding $2,400 while improving treatment quality.

Visit Patient Engagement Systems